Parkinson's disease (PD) is a neurodegenerative disorder primarily affecting the motor system. As healthcare professionals, a comprehensive understanding of PD is essential for effective diagnosis and management.
The exact cause of PD remains unknown. However, it is widely accepted that a combination of genetic and environmental factors plays a significant role. The disease is characterized by the death of dopamine-producing neurons in the substantia nigra, a region in the midbrain, leading to a dopamine deficiency.
PD typically presents with motor symptoms such as bradykinesia, resting tremor, and rigidity. Non-motor symptoms, including autonomic dysfunction, cognitive impairment, and mood disorders, may also be present. The progression of symptoms varies widely among patients.
PD is primarily diagnosed based on clinical criteria, including the presence of bradykinesia and either resting tremor or rigidity. Neuroimaging techniques, such as DaTSCAN, can support the diagnosis, but they are not routinely used due to their high cost and limited availability.
Management of PD focuses on symptomatic treatment. Pharmacotherapy, including levodopa and dopamine agonists, is the mainstay of treatment. Non-pharmacological approaches such as physiotherapy and occupational therapy also play a crucial role. In advanced stages, deep brain stimulation may be considered.
PD is a complex neurodegenerative disorder with a multifaceted clinical presentation. Understanding its etiology, recognizing its symptoms, and being familiar with the current diagnostic and treatment strategies are key to providing optimal care for patients with PD. As we continue to delve deeper into the intricacies of this disease, we can hope to improve both the quality of life and lifespan of those affected.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation